Theratechnologies, Inc.(Toronto Stock Exchange : THTX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Pharmaceuticals Major
|MRK||Merck & Co., Inc.||1.82%||78.56||0.7%||$1560.18m|
|JNJ||Johnson & Johnson||2.49%||164.10||0.7%||$1002.11m|
|BMY||Bristol-Myers Squibb Co.||0.82%||57.41||1.0%||$656.74m|
|LLY||Eli Lilly & Co.||0.64%||240.52||1.1%||$613.28m|
|NVO||Novo Nordisk A/S||1.17%||104.64||0.1%||$91.69m|
|EDSA||Edesa Biotech, Inc.||5.75%||8.19||0.0%||$74.98m|
|CRVS||Corvus Pharmaceuticals, Inc.||-0.22%||4.61||0.7%||$56.38m|
Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in MontrÃ©al, Canada.